Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT02792270
- Status
- Recruiting
Conditions
- Tumor Surgery
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Caloric Restriction Diet — OTHERTwo nutritional supplements, one from Ensure (Abbott Laboratories, Chicago, IL) and one from Boost (Nestle, Vevey, Switzerland) will be used for 3 days before surgery. The supplements are the Ensure Pre-Surgery Clear Carbohydrate Drink and the Ensure Original Nutrition Powder. The Original Nutrition Powder will be mixed with 8oz of water, oat milk, or almond milk. The proposed macronutrient profile for the 3 days of caloric restriction (CR) is less than 8% of calories from protein.
Study Details
This study is being conducted to decrease the rate of surgical wound complications. The investigators are studying the effects that caloric restriction has on decreasing the rate of surgical wound complications.
Key Dates
- Start date
- Jun 30, 2016
- Status verified
- May 2026
- Primary completion
- Aug 31, 2026
- Completion
- May 31, 2027
Study Design
- Enrollment
- 32 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Caloric Restriction DietPatients will meet with the Registered Dietitian to discuss calorie, protein, and fluid needs.The dietitian will calculate calorie needs. * Calorie needs will be reduced by 30%. * Protein needs will be estimated based on 0.8g/kg BW and then reduced by 70%. * Dietitian will educate participants on electrolytes and fluid intake based on the reduced food intake.
- No Intervention: Normal DietParticipant will follow a normal diet.
Primary Outcome Measure
Change In The Rate Of Physical Function By MSTS [ Time Frame: Baseline, 6 weeks, 3 months and 6 months visits after surgery ]
Central Contacts
- Santiago A Lozano-Calderón, MD, PhD617-643-4947
- Shreya Halur, BS617-726-4932
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts general Hospital | Boston | Massachusetts | 02114 | Santiago A Lozano-Calderón, MD,PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By research site